StockData
Lantern Pharma Inc. logo

Lantern Pharma Inc. (LTRN) stock

LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 5/30
$0.33−0.04 (-9.78%)

Close on Nov 18, 2026Market cap $4.21MP/E –Yield –

Lantern Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Lantern Pharma

Lantern Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lantern Pharma figures

See a number that looks wrong?